[Hemocoagulation disorder in patients with destructive pancreatitis: the role in pathogenesis and ways of its correction].
The dynamics of hemocoagulation system changes in patients with different clinical forms of destructive pancreatitis (DP) was evaluated. The necessity of use of directed hemocoagulation therapy and hemocorrection, in particular, the use of low-molecular weight heparins, in complex program of treatment of DP is proved.
Zemskov
V S
VS
Kriuchyna
Ie A
IeA
Koval's'ka
I A
IA
D000925:Anticoagulants / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D019283:Pancreatitis, Acute Necrotizing / Q000150:complications*; D012189:Retrospective Studies; D013927:Thrombosis / Q000209:etiology / Q000473:pathology
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight